AAAAAA

   
Results: 1-20 |
Results: 20
DEXAMETHASONE, CYCLOPHOSPHAMIDE, IDARUBICIN AND ETOPOSIDE (DC-IE) - ANOVEL, INTENSIVE INDUCTION CHEMOTHERAPY REGIMEN FOR PATIENTS WITH HIGH-RISK MULTIPLE-MYELOMA
Authors: BALLESTER OF MOSCINSKI LC FIELDS KK HIEMENZ JW ZORSKY PE GOLDSTEIN SC SABA HI SPIERS ASD KRONISH L SULLIVAN P ELFENBEIN GJ
Citation: Of. Ballester et al., DEXAMETHASONE, CYCLOPHOSPHAMIDE, IDARUBICIN AND ETOPOSIDE (DC-IE) - ANOVEL, INTENSIVE INDUCTION CHEMOTHERAPY REGIMEN FOR PATIENTS WITH HIGH-RISK MULTIPLE-MYELOMA, British Journal of Haematology, 96(4), 1997, pp. 746-748
NEPHROTOXICITY OF HIGH-DOSE IFOSFAMIDE CARBOPLATIN/ETOPOSIDE IN ADULTS UNDERGOING AUTOLOGOUS STEM-CELL TRANSPLANTATION/
Authors: AGALIOTIS DP BALLESTER OF MATTOX T HIEMENZ JW FIELDS KK ZORSKY PE GOLDSTEIN SC PERKINS JB ROSEN RM ELFENBEIN GJ
Citation: Dp. Agaliotis et al., NEPHROTOXICITY OF HIGH-DOSE IFOSFAMIDE CARBOPLATIN/ETOPOSIDE IN ADULTS UNDERGOING AUTOLOGOUS STEM-CELL TRANSPLANTATION/, The American journal of the medical sciences, 314(5), 1997, pp. 292-298
MAXIMUM-TOLERATED DOSES OF IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE GIVEN OVER 6 DAYS FOLLOWED BY AUTOLOGOUS STEM-CELL RESCUE - TOXICITY PROFILE
Authors: FIELDS KK ELFENBEIN GJ LAZARUS HM COOPER BW PERKINS JB CREGER RJ BALLESTER OF HIEMENZ JH JANSSEN WE ZORSKY PE
Citation: Kk. Fields et al., MAXIMUM-TOLERATED DOSES OF IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE GIVEN OVER 6 DAYS FOLLOWED BY AUTOLOGOUS STEM-CELL RESCUE - TOXICITY PROFILE, Journal of clinical oncology, 13(2), 1995, pp. 323-332
LACK OF DIFFERENCE IN RATE OF HEMATOPOIETIC RECOVERY AFTER BONE-MARROW AND PERIPHERAL-BLOOD STEM-CELL INFUSION VERSUS PERIPHERAL-BLOOD STEM-CELLS ALONE
Authors: PERKINS JB ELFENBEIN GJ JANSSEN WE FIELDS KK BALLESTER OF HIEMENZ JW ZORSKY PE GOLDSTEIN SC
Citation: Jb. Perkins et al., LACK OF DIFFERENCE IN RATE OF HEMATOPOIETIC RECOVERY AFTER BONE-MARROW AND PERIPHERAL-BLOOD STEM-CELL INFUSION VERSUS PERIPHERAL-BLOOD STEM-CELLS ALONE, Experimental hematology, 23(8), 1995, pp. 761-761
IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE - A NEW REGIMEN WITH A BROAD-SPECTRUM OF ACTIVITY
Authors: FIELDS KK ZORSKY PE HIEMENZ JW KRONISH LE ELFENBEIN GJ
Citation: Kk. Fields et al., IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE - A NEW REGIMEN WITH A BROAD-SPECTRUM OF ACTIVITY, Journal of clinical oncology, 12(3), 1994, pp. 544-552
PERIPHERAL-BLOOD STEM-CELLS DO NOT ALWAYS PRODUCE FASTER ENGRAFTMENT THAN BONE-MARROW IN AUTOTRANSPLANTATION
Authors: JANSSEN WE HIEMENZ JW FIELDS KK ZORSKY PE BALLESTER OF GOLDSTEIN SC SMILEE R KRONISH L ELFENBEIN GJ
Citation: We. Janssen et al., PERIPHERAL-BLOOD STEM-CELLS DO NOT ALWAYS PRODUCE FASTER ENGRAFTMENT THAN BONE-MARROW IN AUTOTRANSPLANTATION, Experimental hematology, 22(8), 1994, pp. 765-765
EVENT-FREE SURVIVAL IN BREAST-CANCER PATIENTS TREATED WITH HIGH-DOSE IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE AND AUTOLOGOUS STEM-CELL RESCUE- ANALYSIS OF RISK-FACTORS
Authors: FIELDS KK ELFENBEIN GJ PERKINS JP BALLESTER OF HIEMENZ JW ZORSKY PE
Citation: Kk. Fields et al., EVENT-FREE SURVIVAL IN BREAST-CANCER PATIENTS TREATED WITH HIGH-DOSE IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE AND AUTOLOGOUS STEM-CELL RESCUE- ANALYSIS OF RISK-FACTORS, Experimental hematology, 22(8), 1994, pp. 779-779
TIME TO RELAPSE AFTER HIGH-DOSE CHEMOTHERAPY WITH 2 NOVEL REGIMENS FOR METASTATIC BREAST-CANCER
Authors: ELFENBEIN GJ FIELDS KK PERKINS JB BALLESTER OF GOLDSTEIN SC HIEMENZ JW ZORSKY PE
Citation: Gj. Elfenbein et al., TIME TO RELAPSE AFTER HIGH-DOSE CHEMOTHERAPY WITH 2 NOVEL REGIMENS FOR METASTATIC BREAST-CANCER, Experimental hematology, 22(8), 1994, pp. 780-780
DIFFERENCES IN ENGRAFTMENT RATE BETWEEN 2 GROUPS OF BREAST-CANCER PATIENTS TREATED WITH THE SAME HIGH-DOSE CHEMOTHERAPY REGIMEN - POTENTIALCONTRIBUTING FACTORS FOR HEMATOPOIETIC RECOVERY
Authors: PERKINS JB CREMERS KA FIELDS KK JANSSEN WE BALLESTER OF GOLDSTEIN SC HIEMENZ JW ZORSKY PE ELFENBEIN GJ
Citation: Jb. Perkins et al., DIFFERENCES IN ENGRAFTMENT RATE BETWEEN 2 GROUPS OF BREAST-CANCER PATIENTS TREATED WITH THE SAME HIGH-DOSE CHEMOTHERAPY REGIMEN - POTENTIALCONTRIBUTING FACTORS FOR HEMATOPOIETIC RECOVERY, Experimental hematology, 22(8), 1994, pp. 782-782
PATTERNS OF PLATELET RECOVERY AFTER BUSULFAN CYCLOPHOSPHAMIDE AND PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN PATIENTS WITH HEMATOLOGICALMALIGNANCIES/
Authors: BALLESTER OF AGALIOTIS DP JANSSEN WE FIELDS KK HIEMENZ JW ZORSKY PE GOLDSTEIN SC ELFENBEIN GJ
Citation: Of. Ballester et al., PATTERNS OF PLATELET RECOVERY AFTER BUSULFAN CYCLOPHOSPHAMIDE AND PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN PATIENTS WITH HEMATOLOGICALMALIGNANCIES/, Experimental hematology, 22(8), 1994, pp. 782-782
HIGH-DOSE IFOSFAMIDE CARBOPLATIN/ETOPOSIDE - MAXIMUM TOLERABLE DOSES,TOXICITIES, AND HEMATOPOIETIC RECOVERY AFTER AUTOLOGOUS STEM-CELL REINFUSION/
Authors: FIELDS KK ELFENBEIN GJ PERKINS JB JANSSEN WE BALLESTER OF HIEMENZ JW ZORSKY PE KRONISH LE FOODY MC
Citation: Kk. Fields et al., HIGH-DOSE IFOSFAMIDE CARBOPLATIN/ETOPOSIDE - MAXIMUM TOLERABLE DOSES,TOXICITIES, AND HEMATOPOIETIC RECOVERY AFTER AUTOLOGOUS STEM-CELL REINFUSION/, Seminars in oncology, 21(5), 1994, pp. 86-92
GRANULOCTE RECOVERY IS NOT DIFFERENT FOLLOWING AUTOTRANSPLANT WITH G-CSF PRIMED BONE-MARROW OR G-CSF MOBILIZED PERIPHERAL-BLOOD STEM-CELLS
Authors: JANSSEN WE PERKINS J HIEMENZ JW FIELDS KK ZORSKY PE BALLESTER OF GOLDSTEIN SC SMILEE R KRONISH L ELFENBEIN GJ
Citation: We. Janssen et al., GRANULOCTE RECOVERY IS NOT DIFFERENT FOLLOWING AUTOTRANSPLANT WITH G-CSF PRIMED BONE-MARROW OR G-CSF MOBILIZED PERIPHERAL-BLOOD STEM-CELLS, Blood, 84(10), 1994, pp. 10000095-10000095
PHASE I-II TRIAL OF DC-IE - A NOVEL, INTENSIVE INDUCTION CHEMOTHERAPYREGIMEN FOR MULTIPLE-MYELOMA (MM)
Authors: BALLESTER OF MOSCINSKI LC FIELDS KK HIEMENZ JW ZORSKY PE GOLDSTEIN SC SABA HI SPIERS ASD KRONISH LE ELFENBEIN GJ
Citation: Of. Ballester et al., PHASE I-II TRIAL OF DC-IE - A NOVEL, INTENSIVE INDUCTION CHEMOTHERAPYREGIMEN FOR MULTIPLE-MYELOMA (MM), Blood, 84(10), 1994, pp. 10000179-10000179
USE OF GM-CSF (LEUKINE(R) SARGRAMOSTIM) AS A CHEMOPROTECTANT PRIOR TOIFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE - PRELIMINARY-RESULTS OF A RANDOMIZED, CONTROLLED TRIAL
Authors: PERKINS JB FIELDS KK ELFENBEIN GJ BALLESTER OF GOLDSTEIN SC HIEMENZ JW ZORSKY PE
Citation: Jb. Perkins et al., USE OF GM-CSF (LEUKINE(R) SARGRAMOSTIM) AS A CHEMOPROTECTANT PRIOR TOIFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE - PRELIMINARY-RESULTS OF A RANDOMIZED, CONTROLLED TRIAL, Blood, 84(10), 1994, pp. 10000585-10000585
EVENT-FREE SURVIVAL IN PATIENTS WITH METASTATIC BREAST-CANCER UNDERGOING HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW OR PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION
Authors: AGALIOTIS DP FIELDS KK BALLESTER OF HIEMENZ JW ZORSKY PE JANSSEN WE PERKINS JB PACH LD ELFENBEIN GJ
Citation: Dp. Agaliotis et al., EVENT-FREE SURVIVAL IN PATIENTS WITH METASTATIC BREAST-CANCER UNDERGOING HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW OR PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION, Experimental hematology, 21(8), 1993, pp. 1130-1130
MOBILIZATION OF PERIPHERAL-BLOOD STEM-CELLS - COMPARING CELL COLLECTIONS FROM CYCLOPHOSPHAMIDE AND GROWTH-FACTOR BASED REGIMENS
Authors: JANSSEN WE HIEMENZ J ZORSKY PE FIELDS KK BALLESTER O PERKINS J KRONISH L SMILEE R CARTER R RAHN D ELFENBEIN GJ
Citation: We. Janssen et al., MOBILIZATION OF PERIPHERAL-BLOOD STEM-CELLS - COMPARING CELL COLLECTIONS FROM CYCLOPHOSPHAMIDE AND GROWTH-FACTOR BASED REGIMENS, Experimental hematology, 21(8), 1993, pp. 1164-1164
FACTORS AFFECTING THE RATE OF ENGRAFTMENT FOLLOWING AUTOLOGOUS STEM-CELL RESCUE - CONDITIONING REGIMEN
Authors: ELFENBEIN GJ JANSSEN WE HIEMENZ JW FIELDS KK ZORSKY PE BALLESTER OF PERKINS JB
Citation: Gj. Elfenbein et al., FACTORS AFFECTING THE RATE OF ENGRAFTMENT FOLLOWING AUTOLOGOUS STEM-CELL RESCUE - CONDITIONING REGIMEN, Experimental hematology, 21(8), 1993, pp. 1164-1164
FACTORS AFFECTING THE RATE OF ENGRAFTMENT FOLLOWING AUTOLOGOUS STEM-CELL REINFUSION - METHODS OF PERIPHERAL-BLOOD STEM-CELL MOBILIZATION
Authors: HIEMENZ JW JANSSEN WE FIELDS KK ZORSKY PE BALLESTER OF PERKINS JB ELFENBEIN GJ
Citation: Jw. Hiemenz et al., FACTORS AFFECTING THE RATE OF ENGRAFTMENT FOLLOWING AUTOLOGOUS STEM-CELL REINFUSION - METHODS OF PERIPHERAL-BLOOD STEM-CELL MOBILIZATION, Experimental hematology, 21(8), 1993, pp. 1164-1164
OPTIMIZING HIGH-DOSE THERAPY USING PHARMACOKINETIC PRINCIPLES
Authors: ZORSKY PE PERKINS JB
Citation: Pe. Zorsky et Jb. Perkins, OPTIMIZING HIGH-DOSE THERAPY USING PHARMACOKINETIC PRINCIPLES, Seminars in oncology, 20(5), 1993, pp. 2-18
2 NOVEL HIGH-DOSE TREATMENT REGIMENS FOR METASTATIC BREAST-CANCER - IFOSFAMIDE, CARBOPLATIN, PLUS ETOPOSIDE AND MITOXANTRONE PLUS THIOTEPA - OUTCOMES AND TOXICITIES
Authors: FIELDS KK ELFENBEIN GJ PERKINS JB HIEMENZ JW JANSSEN WE ZORSKY PE BALLESTER OF KRONISH LE FOODY MC
Citation: Kk. Fields et al., 2 NOVEL HIGH-DOSE TREATMENT REGIMENS FOR METASTATIC BREAST-CANCER - IFOSFAMIDE, CARBOPLATIN, PLUS ETOPOSIDE AND MITOXANTRONE PLUS THIOTEPA - OUTCOMES AND TOXICITIES, Seminars in oncology, 20(5), 1993, pp. 59-66
Risultati: 1-20 |